The Sensex fell 721 points and the Nifty 50 dropped 225 points amid foreign fund withdrawals. Analysts predict upcoming ...

Cipla Ltd ( ($IN:CIPLA) ) has provided an announcement. Cipla Ltd has released its unaudited financial results for the quarter ended June 30, ...

Despite US tariff concerns, India's pharmaceutical exports are projected to double to $65 billion by 2030. This growth is ...

Bank of Baroda reported net profit at Rs 4,541 crore for Q1 FY26. This marks a 2 percent rise from the Rs 4,458 crore net ...

Companies must indeed think more as a group, while rejecting groupthink. It will help build more inclusive and cohesive teams ...

The 100-day EMA zone of 24,600-24,550 will act as immediate support for the Nifty 50. Any sustainable move below the level of ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

The market is expected to remain in a consolidation phase amid continued uncertainty around the India-US trade deal, a mixed ...

The Indian stock market bourses are expected to face a volatile week ahead given it has to react to a mixed bag of domestic and global cues like nearing Trump's tariff deadline, and Fed Reserve meet.

This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.

The Indian market closed at a one-month low on Friday, extending its longest weekly losing streak of 2025 amid a broad market ...